BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 18, 2012
View Archived Issues
Novel TTK inhibitors patented by Bayer Schering Pharma
Read More
Array BioPharma synthesizes novel kinase inhibitors
Read More
Allergan patents new CCR2 receptor antagonists
Read More
Novel protein kinase inhibitors disclosed by Roche
Read More
German researchers present new GPR119 receptor agonists
Read More
Abbott designs new potential hepatitis therapies
Read More
AbOs-targeted antibodies show potential in Alzheimer's disease model
Read More
Abbott halts development of two clinical-stage candidate drugs for Alzheimer's disease
Read More
New AHA/ACC guideline update includes ticagrelor
Read More
New candidate biomarker for prostate cancer discovered
Read More
Eisai and Verastem enter research collaboration
Read More
AstraZeneca plans to evaluate ticagrelor in patients with PAD
Read More
Oncolytic virus research collaboration begins for bladder cancer
Read More
Phase II results presented on insulin analogue for diabetes
Read More
German authorities approve SkyePharma's asthma product
Read More
FDA advisory committee to discuss NDAs for Novo Nordisk insulin products
Read More
FDA approves VIVUS drug for weight management
Read More
U.S. scientists develop new model of early-onset Alzheimer's disease
Read More
Orphan medicinal product designation granted for levoglutamide
Read More
Janssen seeks U.S. and E.U. approval for Simponi
Read More
Grifols to conduct safety study of inhaled alpha1-proteinase inhibitor
Read More
Medgenics commences Israeli study of Epodure Biopumps
Read More
Isotechnika receives further funding from Canadian government
Read More
Nymox provides update on pivotal U.S. phase III trials in BPH
Read More
Antisense Therapeutics executes agreement for ATL-1102
Read More
FDA grants orphan drug status to antibody-drug conjugate in mesothelioma
Read More
Soligenix receives grant for acute radiation syndrome therapy
Read More